BAYER AG |
Market Closed -
Other stock markets
|
After market 10:30:04 pm | |||
| 28.13 EUR | +2.85% |
|
28.24 | +0.39% |
| 06:41pm | European Equities Close Mostly Lower in Thursday Trading; Eurozone Manufacturing Remains in Contraction | MT |
| 06:37pm | Manufacturing Downturn Keeps German Stocks Lower | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
14/05/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
27.35
EUR
Average target price
36.9
EUR
Spread / Average Target
+34.94%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.35% | 28.7B | |
| +30.31% | 699B | |
| +25.07% | 571B | |
| -4.61% | 364B | |
| +18.11% | 326B | |
| +2.92% | 286B | |
| +14.68% | 236B | |
| +4.71% | 198B | |
| -12.43% | 194B | |
| -3.28% | 154B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer : To Acquire Noria, PSMA Therapeutics
